NVAX - ノババックス (Novavax Inc.) ノババックス

 NVAXのチャート


 NVAXの企業情報

symbol NVAx
会社名 Novavax Inc. (ノババックス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ノババックス(Novavax Inc.)は臨床段階のバイオ医薬品会社である。同社は組換えナノ粒子ワクチン及びアジュバントの発見・開発・商業化に焦点を当てる。同社は組換えワクチンセグメントの開発を通じて事業を行っている。同社は、組換えナノ粒子ワクチン技術を用いて、既知疾患及び新興疾患に対応するワクチン候補物質を製造する。同社の製品パイプラインは、呼吸器合胞体ウイルス(RSV)、季節性インフルエンザ、パンデミックインフルエンザおよびエボラウイルス(EBOV)の臨床開発におけるワクチン候補の感染症に焦点を当てる。同社の人用鉛アジュバントであるMatrix-Mは、パンデミックインフルエンザH7N9ワクチン候補のフェーズI / II臨床試験にある。また、第I相臨床試験でEBOVワクチン候補と併せてMatrix-Mを試験している。同社は中東呼吸器症候群(MERS)を含む感染性疾患で、前臨床段階の追加プログラムを開発している。   ノババックスは、臨床段階の米国バイオ医薬品企業。組換えナノ粒子ワクチンおよび抗原性補強剤の発見、開発、商業化に従事する。呼吸器合胞体ウイルス、季節性インフルエンザと新型インフルエンザのための臨床開発などの感染症に対象を当て遺伝子組み換えによるワクチンを開発する。   Novavax, Inc. is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. Novavax is conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults and will be advanced for regulatory submission. Both vaccine candidates incorporate Novavax' proprietary saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies.
本社所在地 20 Firstfield Road Garthersburg MD 20878 USA
代表者氏名 James Francis Young ジェームズ・フランシス・ヤング
代表者役職名 Independent Chairman of the Board
電話番号 +1 240-268-2000
設立年月日 1987年
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 347人
url www.novavax.com
nasdaq_url https://www.nasdaq.com/symbol/nvax
adr_tso
EBITDA EBITDA(百万ドル) -165.13200
終値(lastsale) 2.065
時価総額(marketcap) 790052064.935
時価総額 時価総額(百万ドル) 723.09850
売上高 売上高(百万ドル) 39.19000
企業価値(EV) 企業価値(EV)(百万ドル) 874.46250
当期純利益 当期純利益(百万ドル) -186.29300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Novavax Inc. revenues increased 65% to $20.4M. Net loss increased 3% to $90.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing increase of 16% to $83.5M (expense) Labor_Related Expenses in R&D increase of 18% to $5.6M (expense).

 NVAXのテクニカル分析


 NVAXのニュース

   Stock Jumping on Abnormally High Volume: Novavax, Inc. (NASDAQ:NVAX), Qutoutiao Inc. (NASDAQ:QTT)  2021/07/07 22:19:30 Stock Equity
Novavax, Inc. (NASDAQ:NVAX) with the stream of -11.32% also noticed, India Qutoutiao Inc. (NASDAQ:QTT) encountered a rapid change of -5.56% in the last hour of Wednesdays trading session. Novavax, Inc. The post Stock Jumping on Abnormally High Volume: Novavax, Inc. (NASDAQ:NVAX), Qutoutiao Inc. (NASDAQ:QTT) appeared first on Stocks Equity .
   NVAX Stock: One Big Reason Novavax Is Struggling Today  2021/07/07 19:44:29 InvestorPlace
Today''s significant selloff appears to be tied at least in part to some large stock sales made by the company''s CEO earlier this month.
   Novavax Stock Should Take Off as Its Successful Covid-19 Vaccine Spreads  2021/07/07 14:37:41 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax should take off as its successful Covid-19 vaccine spreads. NVAX stock is worth at least 50% more, given a mixture of analysts estimates and comp analysis. The post Novavax Stock Should Take Off as Its Successful Covid-19 Vaccine Spreads appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now It doesnt matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner
   1.5M Novavax doses arriving in August for Cavite, says governor  2021/07/07 13:32:12 Rappler
Cavite Governor Jonvic Remulla says that though they are still waiting for the approval of the Emergency Use Authorization of Novavax, the province has finalized orders for the vaccine
   The Real Value of Novavax Lies in Its Pipeline, Not the Pandemic  2021/07/07 10:00:57 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NVAX stock is beginning to look like all the good news is priced in. However, a successful Covid-19 vaccine may be a catalyst for other vaccines. The post The Real Value of Novavax Lies in Its Pipeline, Not the Pandemic appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now It doesnt matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner
   Novavax bibigyan na ng EUA ng FDA  2021/07/04 04:42:24 Remate News Online
MANILA, Philippines Inaasahang pagkalooban na ng Food and Drug Administration (FDA) ang Novavax COVID-19 vaccine na epektibo kontra Delta variant. Ang possible so far yung Novavax, isang bakuna na na-develop sa US and India na very promising din at mukhang maganda sa Delta variant. Nag-publish na sila ng result, ayon kay FDA Director General [] The post Novavax bibigyan na ng EUA ng FDA appeared first on REMATE ONLINE .
   Jakých vakcín proti covidu se jet dokáme? Moného favorita i propadlíka od soused  2021/07/04 03:10:00 Blesk Zprávy
V esku u se sice okuje tymi vakcínami proti covidu, stále to ale nejsou vechny, se kterými tuzemská okovací strategie poítá. Ti jet chybí, piem do ordinací a center nedorazí díve jak za nkolik msíc. Dvody jsou rzné, napíklad u vakcíny Novavax je to dané odlinou technologií ne u ji schválených vakcín. Je komplikovanjí na vývoj, zato se me chlubit pikovou úinností. Oproti tomu vakcína CureVac narazila na problém, prbné testy odhalily, e funguje sotva na 47 procent.
   Cwpl sy''n rhan o dreial Novavax methu mynd dramor  2021/07/03 07:28:13 BBC UK
"Roedden wedi cael ar ddeall nad oeddem o dan unrhyw anfantais," medd y cwpl o Wrecsam.
   Taiwan to obtain variant-busting Novavax shots through COVAX global sharing scheme in bid to boost lagging inoculation campaign RT World News  2021/07/02 23:22:04 State Of Press
Taiwan has chosen to receive Novavaxs much-touted Covid-19 shots through the COVAX vaccine sharing initiative, with the island in severe need of speeding up its inoculation campaign to prevent further outbreaks. In an emailed statement on Friday, US biotech firm Novavax said Taiwan would become a recipient of its Covid-19 vaccine. Taiwan has opted to
   Covid: Call to let Novavax volunteers have second vaccine  2021/07/02 21:49:00 BBC UK
Volunteers "frustrated and angry" at now not being able to travel abroad after vaccine trial.
   Novavax to expand COVID-19 vaccine trials to children, teens  2021/04/05 20:31:50 MarketWatch
Novavax Inc. undefined said late Monday it plans to expand its COVID-19 vaccine trials to include children and teens by the second quarter. The biotech also…
   ¿Cómo funciona la vacuna Novavax contra el covid-19?  2021/04/02 18:48:49 CNN Spain
La vacuna contra el coronavirus de Novavax, llamada NVX-CoV2373, se basa en tecnología de nanopartículas recombinantes y el adyuvante de Novavax
   How the Novavax Covid-19 vaccine works  2021/04/01 20:54:20 CNN
At the headquarters of biotechnology company Novavax, scientists are developing what they hope could soon be another Covid-19 vaccine for the United States.
   Poland's Mabion aims to produce Novavax vaccine for Europe from third quarter  2021/04/01 13:12:00 Yahoo News
Poland's Mabion aims to start production of U.S. firm Novavax's coronavirus vaccine for Europe from the third quarter, representatives of the biotechnology company said. Mabion and Novavax last month signed a framework deal on the transfer of COVID-19 vaccine technology to Mabion's plant in central Poland, which was designed to produce a rare diseases drug yet to be registered. "The production of our core product is much more complicated (than vaccine)," Mabion board member Adam Pietruszkiewicz told Reuters.
   Where have I found peace in the pandemic? Taking part in a Covid vaccine trial  2021/03/31 15:00:30 The Guardian
The time I’ve spent testing Novavax is the closest I’ve come to the eye of the storm – and it has put my other worries into perspective I’ve thoroughly enjoyed being a vaccine triallist. As I’ve mentioned before, I’m on the Novavax trial . When I look back on this past year, I’ll remember my visits to the hospital with fondness. I’ve found them to be pleasant little diversions from the rhythm of my locked-down life. I just bowl in and everyone seems vaguely glad I’ve made the effort. I’m pleased to see them, too, although I know them only by their eyes, hair arrangements and voices. It’s an odd thing that I’ll probably never get to see their faces; once it’s over, I’ll be able to walk past them in the street, or at a pub, a gig or a football match, or wherever unmasked top trial types hang out, and not know them from Adam or Eve. And vice versa, I suppose. Continue reading…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ノババックス NVAX Novavax Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)